Infectious Diseases News and Research

RSS

Antibiotic-resistant bacteria share resources to cause chronic infections, show studies

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt University investigators have discovered.

20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

Ebola Virus and Public Health: A special feature by Disaster Medicine and Public Health

Accurate knowledge regarding Ebola is critical and pertinent for practicing physicians and clinicians given the current risk of hazardous global outbreak and epidemic.

17 Oct 2014

Viewpoints: Examining the U.S. Ebola response, possible solutions, facts vs. fear, and the need for candor

The Ebola cases in the United States show that American hospitals and public health officials have much to learn about effective ways to protect health care workers and the public from possible infection.

17 Oct 2014

CDC, Obama under fire for Ebola containment policies

The Centers for Disease Control and Prevention Chief Thomas Frieden faced criticism Thursday on Capitol Hill over handling of the Dallas Ebola cases.

17 Oct 2014

Scientific insights into flu viruses must not give way to complacency, say researchers

As our ability to assess the pandemic risk from strains of influenza virus increases with the latest scientific developments, we must not allow ourselves to become complacent that the most substantial threats have been identified, argue an international consortium of scientists.

17 Oct 2014

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

Indiana University Bloomington biologists who specialize in the ecology and evolution of microbes have been named one of 12 teams in the nation to receive funding from the National Science Foundation's Dimensions of Biodiversity Program.

17 Oct 2014

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses.

17 Oct 2014

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

In the nine years Parker has now served on the court, he has made the most of his opportunities. Child custody disputes, for instance, have made good occasions to expound on the role of religion in parental rights.

17 Oct 2014

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

For many months, the world has witnessed the Ebola virus spread and claim more than 4,400 lives in West African countries. On Oct. 8, the first confirmed adult Ebola patient identified in the United States died. The constant news coverage has heightened concern among parents who fear their children will become infected. Jill Hoffman, MD, a pediatric Infectious diseases specialist at Children's Hospital Los Angeles, discusses the facts about Ebola, how parents can help their children prevent further outbreak by teaching them good hygiene, and how CHLA is prepared to identify and treat suspected Ebola patients.

16 Oct 2014

Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Understandably, the specter of such a dangerous disease in the United States has bred fear. But it is remarkable how some public figures are inflaming that fear. Commentator Rush Limbaugh took flight on Tuesday, saying on the radio that "I don't think anybody involved with Ebola knows what they're doing. I don't care if it's the WHO or the Centers for Disease Control, I don't think anybody knows what they're doing." This was an unfounded rant that can only deepen public disquiet.

16 Oct 2014

Research initiative focuses on microbial characteristics of Staphylococcus aureus

Staphylococcus aureus (Sa) and methicillin-resistant staph aureus (MRSA) continue to be among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening blood-borne infections.

16 Oct 2014

Four out of ten children in Burkina Faso genetically resistant to virus strains

Every year rotavirus causes half a million diarrhoea-related deaths amongst children in developing countries. Existing vaccines provide poor protection. The reason could be a widespread genetic resistance amongst children, according to virologists at Linköping University.

15 Oct 2014

CDC re-evaluating safety procedures after nurse contracts Ebola

Thomas Frieden, the director of the Centers for Disease Control and Prevention, announces that the agency will look again at the protocols for hospitals to see if more training or equipment is necessary to protect health care workers and the public.

15 Oct 2014

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Scientists from The Scripps Research Institute have been awarded $6.6 million from the National Institutes of Health to lead an investigation of Lassa fever virus, the most prevalent virus-induced hemorrhagic fever disease in Africa.

14 Oct 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Hubris is the greatest danger in wealthy countries - a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.

14 Oct 2014

GenCell Biosystems acquired by Becton, Dickinson and Company

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.

From BD (Becton, Dickinson and Company) 13 Oct 2014

Pharmaceutical industry withdraws from the antibiotic space

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive.

13 Oct 2014

HIV-infected users of stimulants derive benefits from antiretroviral therapy

New clinical research from UC San Francisco shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.

13 Oct 2014

Viewpoints: Effects of health law; conquering Ebola

In case you don't follow me on Twitter, here it is: The Affordable Care Act has already helped slow the rate of growth in health-care costs across the board, putting more money in Americans' pockets and bringing down projected deficits even as millions more people sign up for health insurance and receive access to Medicaid.

13 Oct 2014

Infectious Diseases News and Research

Antibiotic-resistant bacteria share resources to cause chronic infections, show studies

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Ebola Virus and Public Health: A special feature by Disaster Medicine and Public Health

Viewpoints: Examining the U.S. Ebola response, possible solutions, facts vs. fear, and the need for candor

CDC, Obama under fire for Ebola containment policies

Scientific insights into flu viruses must not give way to complacency, say researchers

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Research initiative focuses on microbial characteristics of Staphylococcus aureus

Four out of ten children in Burkina Faso genetically resistant to virus strains

CDC re-evaluating safety procedures after nurse contracts Ebola

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

GenCell Biosystems acquired by Becton, Dickinson and Company

Pharmaceutical industry withdraws from the antibiotic space

HIV-infected users of stimulants derive benefits from antiretroviral therapy

Viewpoints: Effects of health law; conquering Ebola

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News